CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | Cooke Shane Director | Exercise or conversion | +6,142 | 109,886 | ||
| 2026-05-21 | Cooke Shane Director | Shares withheld for taxes | −3,207 | $36.95 | $118K | 106,679 |
| 2026-05-21 | Cooke Shane Director | Exercise or conversion · Restricted Stock Unit Award | −6,142 | 0 | ||
| 2026-05-20 | Cooke Shane Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +11,538 | 11,538 | ||
| 2026-05-20 | Cooke Shane Director | Grant or award · Restricted Stock Unit Award | +5,409 | 5,409 | ||
| 2026-05-20 | Cooke Shane Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +11,538 | 11,538 | ||
| 2026-05-20 | Cooke Shane Director | Grant or award · Restricted Stock Unit Award | +5,409 | 5,409 | ||
| 2026-02-02 | Cooke Shane Director | Exercise or conversion 10b5-1 | +61,200 | $31.64 | $1.9M | 164,944 |
| 2026-02-02 | Cooke Shane Director | Sale 10b5-1 | −29,087 | $34.34 | $999K | 135,857 |
| 2026-02-02 | Cooke Shane Director | Sale 10b5-1 | −32,113 | $34.78 | $1.1M | 103,744 |
| 2026-02-02 | Cooke Shane Director | Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 | −61,200 | 0 | ||
| 2025-05-31 | Cooke Shane Director | Exercise or conversion | +8,013 | 107,919 | ||
| 2025-05-31 | Cooke Shane Director | Shares withheld for taxes | −4,175 | $30.61 | $128K | 103,744 |
| 2025-05-31 | Cooke Shane Director | Exercise or conversion · Restricted Stock Unit Award | −8,013 | 0 | ||
| 2025-05-21 | Cooke Shane Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +13,474 | 13,474 | ||
| 2025-05-21 | Cooke Shane Director | Grant or award · Restricted Stock Unit Award | +6,142 | 6,142 | ||
| 2024-06-29 | Cooke Shane Director | Exercise or conversion | +6,104 | 103,081 | ||
| 2024-06-29 | Cooke Shane Director | Shares withheld for taxes | −3,175 | $24.10 | $77K | 99,906 |
| 2024-06-29 | Cooke Shane Director | Exercise or conversion · Restricted Stock Unit Award | −6,104 | 0 | ||
| 2024-05-31 | Cooke Shane Director | Grant or award · Restricted Stock Unit Award | +8,013 | 8,013 |
Page 1 of 4 · 70 trades